Tech Company Financing Transactions
KalGene Pharmaceuticals Funding Round
KalGene Pharmaceuticals, based in Toronto ON, secured funding from Lumira Capital , Accel-Rx Health Sciences Accelerator and Anges Quebec.
Transaction Overview
Lumira Capital (Lead Investor) (Daniel Hetu)
Accel-Rx Health Sciences Accelerator (Natalie Dakers)
Anges Quebec (François Gilbert)
Company Information
Toronto ON, M3C
Canada
Management Team
Browse more venture capital transactions:
Prev: 11/27/2017: HydroEdge Solutions venture capital transaction
Next: 11/28/2017: Libra venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs